RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Esther Torres to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Esther Torres has written about Antibodies, Monoclonal.
Esther Torres
Connection Strength
0.674
Antibodies, Monoclonal
  1. Torres E, Goicoechea M, Hern?ndez A, Rodr?guez Ferrero ML, Garc?a A, Mac?as N, Anaya F. Efficacy of Evolocumab vs low-density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01). J Clin Apher. 2020 Jan; 35(1):9-17.
    View in: PubMed
    Score: 0.618
  2. S?nchez JM, Maldonado JC, Torres EA, Rivera C. Infliximab in Hispanics: characterization of response to infliximab in an ethnic minority with Crohn's disease. P R Health Sci J. 2005 Mar; 24(1):11-7.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support